Executive Change

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the SECURITIES EXCHANGE ACT OF 1934 _______________________ Date of Report (Date of earliest event reported): January 9, 2024 McCormick & Co Inc. (Exact name of registrant as specified in its charter) Maryland 001-14920 52-0408290 (State or other jurisdiction (Commission (IRS Employer of incorporation) File Number) Identification No.) 24 Schilling Road Suite 1 Hunt Valley Maryland 21031 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code: 410 771-7301 Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below): ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b). ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c). Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock MKC-V New York Stock Exchange Common Stock Non-Voting MKC New York Stock Exchange Indicate by check mark whether the Registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the Registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On January 9, 2024, Dr. Freeman A. Hrabowski, III, informed the Nominating and Corporate Governance Committee of the Board of Directors (the “Board”) of McCormick & Company, Incorporated (the “Registrant”) that he intends to retire from the Board of the Registrant and will not stand for election at the Registrant’s next annual stockholders’ meeting, which is currently scheduled for March 27, 2024. Dr. Hrabowski will continue to serve on the Board until such stockholders’ meeting. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.      McCORMICK & COMPANY, INCORPORATED Date: January 12, 2024 By:   /s/    Jeffery D. Schwartz           Jeffery D. Schwartz   Vice President, General Counsel & Secretary